Statements: GSK Advance Company Ltd

Canonical ID: NK-QfFkwcpTeaFHBpwC4e2GeA · Entity type: Company (reference)

PropertyValueLangSource datasetSource IDFirst seen
Organization:addressAhmed Khair Street, 11111 Khartoum, SUDANeu_fsfeu-fsf-eu-11097-27
Organization:addressAhmed Khair Street, Khartoum, Sudan, 11111enggb_coh_disqualifiedgb-coh-swwsm-n6bfso9gnhc1ioyxrenbq
LegalEntity:addressAHMED KHAIR STREET, 11111 KHARTOUMengus_sam_exclusionsusgsa-cbbbd8dda03b8ab37c752b1dddc69820867948dd
LegalEntity:addressAhmed Khair Street, Khartoum, 11111enggb_hmt_sanctionsgb-hmt-16008
Organization:addressAhmed Khair Street, 11111 Khartoum, Sudanenggb_fcdo_sanctionsgb-fcdo-sud0010
Organization:addressAhmed Khair Street, Khartoum 11111, Soudanframc_fund_freezesmc-freezes-fce8cd441c161d7708ba9c08a326ae53f8e2358e
LegalEntity:addressAHMED KHAIR STREET, 11111 KHARTOUMengus_sam_exclusionsusgsa-4ce337a411f5dba0691eee4b56d3ec020ac2f6a3
Organization:addressAhmed Khair Street, Khartoum 11111frafr_tresor_gels_avoirfr-ga-7112
LegalEntity:addressAhmed Khair Street, 11111 Khartoum, Sudanch_seco_sanctionsch-seco-73715
Organization:addressAhmed Khair Street, 11111 Khartoumengus_ofac_sdnofac-45288
Company:addressSudan (North)permidpermid-5086676964
Organization:addressEntityaddr-f50fc4c4b7795ef4bb918bb67a8a6b4e74e46178eu_fsfeu-fsf-eu-11097-27
LegalEntity:addressEntityaddr-f50fc4c4b7795ef4bb918bb67a8a6b4e74e46178ch_seco_sanctionsch-seco-73715
Organization:addressEntityaddr-7831f5e5a4b15db6451a9a39a9688a36a95cb916us_ofac_sdnofac-45288
LegalEntity:addressEntityaddr-795c2bc9d14fa8d3ca63bacf49c05486ab0eb661gb_hmt_sanctionsgb-hmt-16008
LegalEntity:aliasGSK Advanceenggb_hmt_sanctionsgb-hmt-16008
Organization:aliasGSK for Advanced Business Co. Ltdengus_ofac_sdnofac-45288
LegalEntity:aliasشركة جي أس كيه أدفانس كومباني لميتدca_dfatd_sema_sanctionsca-sema-5e673fd66cb1125630cca1bd07abd7d4d227338f
LegalEntity:aliasGSK Advance Co. Ltd. and GSK for Advanced Business Co. Ltd.ca_dfatd_sema_sanctionsca-sema-5e673fd66cb1125630cca1bd07abd7d4d227338f
LegalEntity:aliasGSK Advanceca_dfatd_sema_sanctionsca-sema-5e673fd66cb1125630cca1bd07abd7d4d227338f
LegalEntity:aliasGSK Advance Co. Ltdenggb_hmt_sanctionsgb-hmt-16008
Organization:countrysdfr_tresor_gels_avoirfr-ga-7112
LegalEntity:countrysdus_sam_exclusionsusgsa-cbbbd8dda03b8ab37c752b1dddc69820867948dd
Organization:countrysdeu_fsfeu-fsf-eu-11097-27
LegalEntity:countrysdca_dfatd_sema_sanctionsca-sema-5e673fd66cb1125630cca1bd07abd7d4d227338f
LegalEntity:countrysdgb_hmt_sanctionsgb-hmt-16008
Company:countrysdext_us_ofac_press_releasesofac-pr-22d1d81406ff76a00df25177a7ff2a38a67110af
LegalEntity:countrysdch_seco_sanctionsch-seco-73715
Company:countrysdpermidpermid-5086676964
Organization:countrysdus_ofac_sdnofac-45288
LegalEntity:countrysdus_sam_exclusionsusgsa-4ce337a411f5dba0691eee4b56d3ec020ac2f6a3
Organization:countrysdgb_fcdo_sanctionsgb-fcdo-sud0010
LegalEntity:createdAt2025-02-13us_sam_exclusionsusgsa-4ce337a411f5dba0691eee4b56d3ec020ac2f6a3
LegalEntity:createdAt2023-07-12gb_hmt_sanctionsgb-hmt-16008
LegalEntity:createdAt2025-02-14us_sam_exclusionsusgsa-cbbbd8dda03b8ab37c752b1dddc69820867948dd
LegalEntity:createdAt2024-04-10ch_seco_sanctionsch-seco-73715
LegalEntity:idfaf8cdf9c5978dc51e41f73542da563d10badfd8us_sam_exclusionsusgsa-4ce337a411f5dba0691eee4b56d3ec020ac2f6a3
Organization:id15ac8505ea6049f523e4e17d5e03d0df66b8113afr_tresor_gels_avoirfr-ga-7112
Organization:id5b7ac4b9574e21ee374811676c8970299ccffbf2gb_fcdo_sanctionsgb-fcdo-sud0010
Organization:idd3e12e942d40ccdcf5500199d3af7a90cc44dd2eus_trade_cslofac-45288
Organization:iddd231b436383d1e5c3dc4cfbb31503bb79e3a49dgb_fcdo_sanctionsgb-fcdo-sud0010
Organization:id1955889075c46fc73cb737596a4ac3a8c4f2381dgb_fcdo_sanctionsgb-fcdo-sud0010
Organization:id10e8ad524d12ca2bac8a4ddaa68d9f81733ec645gb_fcdo_sanctionsgb-fcdo-sud0010
LegalEntity:id4798ba636e906b6de63340a340fce556dd273b54gb_hmt_sanctionsgb-hmt-16008
Organization:id2c2c42b4238ac5d9141d33934c648ced68d6b22cmc_fund_freezesmc-freezes-fce8cd441c161d7708ba9c08a326ae53f8e2358e
Company:id6748437721ea5ff49517461a1e585efe7f036d8fpermidpermid-5086676964
LegalEntity:idb06cd4661a2871ea87eef636c3c1296703074f60ch_seco_sanctionsch-seco-73715
LegalEntity:id7fdca0cd01475f4f8cb6f0fc384aacbccf42b898gb_hmt_sanctionsgb-hmt-16008
LegalEntity:id4b5be32c03997825e0abbf8f7cf23cd14ea7ff84us_sam_exclusionsusgsa-cbbbd8dda03b8ab37c752b1dddc69820867948dd
Organization:id945bc15227070f4b552b7a18c6b043cdf6e2dfecbe_fod_sanctionsbe-fod-deec9d50409099c0bb7f4fffc74ed635088b80b3
LegalEntity:idae0c24f9ebcc0bb0193ec0680f4009d639c3fc57gb_hmt_sanctionsgb-hmt-16008
Company:idd113e1a739fd8a2f36c01ab7a8ef5c72479b7de5ext_us_ofac_press_releasesofac-pr-e39c9029656027cb62b15c26be463d5f9dd17743
LegalEntity:id6dbf189fc25b422d28ee8d6b15d75d81358be2e5us_sam_exclusionsusgsa-4ce337a411f5dba0691eee4b56d3ec020ac2f6a3
Organization:id04681ad63dd5e6b5a7176011e14b906b6d93bab0us_ofac_sdnofac-45288
Organization:idd927eedc26b54da8b07a75d302aa83bff86d5f00eu_fsfeu-fsf-eu-11097-27
Organization:idd6b40ab43bdf3c74f2b8e3cdb03fe8aeb01a638dgb_coh_disqualifiedgb-coh-swwsm-n6bfso9gnhc1ioyxrenbq
Company:idd569d902025e0ce88a466c1848f6e59b4fd1e9d2ext_us_ofac_press_releasesofac-pr-22d1d81406ff76a00df25177a7ff2a38a67110af
LegalEntity:ide10d184d72ac8f85f9f31011542239b3f5b431acca_dfatd_sema_sanctionsca-sema-5e673fd66cb1125630cca1bd07abd7d4d227338f
Company:jurisdictionsdpermidpermid-5086676964
LegalEntity:legalFormLimited Companych_seco_sanctionsch-seco-73715
Organization:legalFormLimited Companyfrafr_tresor_gels_avoirfr-ga-7112
LegalEntity:modifiedAt2023-07-12gb_hmt_sanctionsgb-hmt-16008
LegalEntity:modifiedAt2024-04-10ch_seco_sanctionsch-seco-73715
Organization:modifiedAt2024-01-22eu_fsfeu-fsf-eu-11097-27
Organization:nameGSK ADVANCE COMPANY LTDenggb_coh_disqualifiedgb-coh-swwsm-n6bfso9gnhc1ioyxrenbq
Organization:nameGSK ADVANCE COMPANY LTDframc_fund_freezesmc-freezes-fce8cd441c161d7708ba9c08a326ae53f8e2358e
Company:nameGSK Advance Company Ltdengext_us_ofac_press_releasesofac-pr-22d1d81406ff76a00df25177a7ff2a38a67110af
Company:nameGSK Advanced Business Co Ltdengext_us_ofac_press_releasesofac-pr-e39c9029656027cb62b15c26be463d5f9dd17743
Company:nameGsk Advance Co Ltdpermidpermid-5086676964
LegalEntity:nameGSK ADVANCE COMPANY LTDch_seco_sanctionsch-seco-73715
Organization:nameGSK ADVANCE COMPANY LTDbe_fod_sanctionsbe-fod-deec9d50409099c0bb7f4fffc74ed635088b80b3
Organization:nameGSK Advance Company LTDengus_ofac_sdnofac-45288
LegalEntity:nameGSK Advance Company Ltd.ca_dfatd_sema_sanctionsca-sema-5e673fd66cb1125630cca1bd07abd7d4d227338f
Organization:nameGSK Advanceenggb_fcdo_sanctionsgb-fcdo-sud0010
Organization:nameGSK Advance Company Ltdenggb_fcdo_sanctionsgb-fcdo-sud0010
Organization:nameGSK Advance Co. Ltdenggb_fcdo_sanctionsgb-fcdo-sud0010
Organization:nameGSK ADVANCE COMPANY LTDus_trade_cslofac-45288
Organization:nameGSK ADVANCE COMPANY LTDfrafr_tresor_gels_avoirfr-ga-7112
Organization:nameGSK ADVANCE COMPANY LTDengeu_fsfeu-fsf-eu-11097-27
LegalEntity:nameGSK ADVANCE COMPANY LTDengus_sam_exclusionsusgsa-4ce337a411f5dba0691eee4b56d3ec020ac2f6a3
LegalEntity:nameGSK FOR ADVANCED BUSINESS CO. LTDengus_sam_exclusionsusgsa-cbbbd8dda03b8ab37c752b1dddc69820867948dd
LegalEntity:nameGSK Advance Company Ltdenggb_hmt_sanctionsgb-hmt-16008
Organization:notesType d'entité: société à responsabilité limitée (Limited Company).framc_fund_freezesmc-freezes-fce8cd441c161d7708ba9c08a326ae53f8e2358e
Organization:notesType of entity: Limited Company. 60 % owned by Major Algoney Hamdan Dagaloeu_fsfeu-fsf-eu-11097-27
Organization:notes(Date of UN designation: 2024-01-22)be_fod_sanctionsbe-fod-deec9d50409099c0bb7f4fffc74ed635088b80b3
LegalEntity:notesGSK is a Sudan-based information technology and security company, which is 60 % owned by RSF Major Algoney Hamdan Dagalo, the youngest brother of Mohamed Hamdan Dagalo (Hemedti). GSK is part of the RSF’s commercial network which generates stable revenue for the RSF enabling them to finance and continue the conflict in Sudan. It is used by the RSF as a front company, facilitating cash flows into the RSF and being involved in the RSF’s procurement processes. In addition, since at least 2019, GSK has been working with Aviatrade LLC, a Russia-based military supply company, on the purchase and supply of material and equipment for the benefit of the RSF, including the corresponding training, and on the purchase and supply of unmanned aerial vehicles, monitoring equipment and spare parts. Reconnaissance and weaponised drones are used by the RSF in the conflict in Sudan. Therefore, GSK Advance Company LTD provides support for RSF actions that threaten the peace, stability and security of Sudan.ch_seco_sanctionsch-seco-73715
Organization:notesDisqualifiedenggb_coh_disqualifiedgb-coh-swwsm-n6bfso9gnhc1ioyxrenbq
Organization:notesGSK est une société soudanaise dans le domaine des technologies de l'information et de la sécurité, qui est détenue, à 60 % de l'actionnariat, par Algoney Hamdan Dagalo, commandant au sein des FSR et le plus jeune frère de Mohamed Hamdan Dagalo (Hemedti). GSK fait du réseau commercial des FSR qui génère un revenu stable pour les FSR leur permettant de financer et de poursuivre le conflit au Soudan. Elle est utilisée par les FSR comme société écran, facilitant les flux de liquidités vers les FSR et impliquée dans les procédures de passation de marchés des FSR. En outre, depuis au moins 2019, GSK travaille avec Aviatrade LLC, une entreprise d'approvisionnement militaire établie en Russie, pour l'achat et la fourniture de matériel et d’équipements au profit des FSR, y compris la formation correspondante, et pour l’achat et la fourniture de véhicules aériens sans pilote, d’équipements de surveillance et de pièces détachées. Des drones de reconnaissance et piégés sont utilisés par les FSR dans le conflit au Soudan. Par conséquent, GSK Advance Company LTD apporte un soutien aux actions des FSR qui menacent la paix, la stabilité et la sécurité du Soudan.frafr_tresor_gels_avoirfr-ga-7112
LegalEntity:notes(also GSK FOR ADVANCED BUSINESS CO. LTD, GSK FOR ADVANCED BUSINESS CO. LTD)engus_sam_exclusionsusgsa-4ce337a411f5dba0691eee4b56d3ec020ac2f6a3
Organization:notesThe Director Disqualification Sanction was imposed on 09/04/2025.enggb_fcdo_sanctionsgb-fcdo-sud0010
LegalEntity:notes(also GSK ADVANCE COMPANY LTD)engus_sam_exclusionsusgsa-cbbbd8dda03b8ab37c752b1dddc69820867948dd
Company:permId5086676964permidpermid-5086676964
Organization:phone+249930020401gb_fcdo_sanctionsgb-fcdo-sud0010
LegalEntity:phone+249930020401gb_hmt_sanctionsgb-hmt-16008
LegalEntity:programIdSECO-SUDANch_seco_sanctionsch-seco-73715
Organization:programIdGB-SDNenggb_fcdo_sanctionsgb-fcdo-sud0010
Organization:programIdEU-SDNZeu_fsfeu-fsf-eu-11097-27
LegalEntity:programIdCA-SEMAca_dfatd_sema_sanctionsca-sema-5e673fd66cb1125630cca1bd07abd7d4d227338f
LegalEntity:programIdGB-SDNenggb_hmt_sanctionsgb-hmt-16008
Organization:programIdEU-SDNZfrafr_tresor_gels_avoirfr-ga-7112
OpenSanctions · Supreme Data on Supreme Leaders
OpenSanctions Datenbanken GmbH · info@opensanctions.org · https://opensanctions.org/meeting